TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 191 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2021. The put-call ratio across all filers is 1.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $41,588,000 | -15.0% | 626,046 | -0.2% | 0.07% | -2.8% |
| Q2 2021 | $48,943,000 | -17.7% | 627,313 | -0.3% | 0.07% | -18.2% |
| Q1 2021 | $59,504,000 | -22.2% | 629,069 | +0.2% | 0.09% | -29.6% |
| Q4 2020 | $76,516,000 | +83.6% | 627,951 | +31.6% | 0.12% | +62.3% |
| Q3 2020 | $41,671,000 | +35.3% | 477,000 | 0.0% | 0.08% | -1.3% |
| Q2 2020 | $30,810,000 | +51.0% | 477,000 | +4.4% | 0.08% | -10.3% |
| Q1 2020 | $20,410,000 | -8.2% | 457,000 | +28.0% | 0.09% | +4.8% |
| Q4 2019 | $22,238,000 | +6.2% | 357,000 | -35.9% | 0.08% | +12.2% |
| Q3 2019 | $20,943,000 | -7.6% | 557,000 | 0.0% | 0.07% | -17.8% |
| Q2 2019 | $22,670,000 | – | 557,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 708,233 | $44,116,000 | 18.91% |
| Corriente Advisors, LLC | 285,000 | $17,753,000 | 9.54% |
| Cormorant Asset Management, LP | 3,396,650 | $211,577,000 | 8.44% |
| Opaleye Management Inc. | 340,500 | $21,210,000 | 4.16% |
| Orbimed Advisors | 2,745,327 | $171,006,000 | 2.44% |
| Parkman Healthcare Partners LLC | 101,434 | $6,318,000 | 1.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,179,000 | 0.78% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 366,000 | $22,798,000 | 0.73% |
| Artal Group S.A. | 300,000 | $18,687,000 | 0.72% |
| DAFNA Capital Management LLC | 30,408 | $1,894,000 | 0.65% |